Pressure on FDA to Enforce Honest Labeling of Trans Fats

Trans fats have been at the center of heated debates for some time—receiving even more scrutiny in the last decade as cases of childhood obesity, hypertension and heart disease are rising significantly. In a recently published article in the American Journal of Health Promotion, Eric Brandt of the Case Western University School of Medicine seeks stricter FDA guidelines on this deadly ingredient, which under current regulations can be deceptively mislabeled.